首页>投融资
Confo Therapeutics
B轮
Confo Therapeutics is a spin-off company of VIB and Vrije Universiteit Brussel focused on drugs targeting G-protein coupled receptors using its proprietary CONFO technology platform.In May 2019, Confo Therapeutics raised EUR 30 million (US $33.4 million) in Series A financing.In June 2015, the company raised EUR 3 million (US $3.37 million) in the first institutional round of investment by a consortium led by Capricorn Health-Tech Fund with the participation of Qbic and SOFI. In February 2016, the company had secured EUR 6.7 million (US $7.47 million) in the first financing round
基本信息
-
公司全称Confo Therapeutics NV
-
类型G蛋白偶联受体研发商
-
产业领域生物/化学技术、药品研发/制造、化学药
-
公司人数15~50人
-
地址Technologiepark-Zwijnaarde 30 GENT OOST-VLAANDEREN 9052; BE;
-
联系电话
-
邮箱info@confotherapeutics.com
-
成立时间2015-01-01
投融资
-
2024-07-26B轮6000万欧元Ackermans & van HaarenDriehaus Capital ManagementQuest for GrowthBioGeneration VenturesCapricorn Health-Tech FundFund+University of MichiganPerceptive AdvisorsQbicPMVV-BIO VenturesVIBWellington Partners
-
2024-03-28捐赠/众筹/授予160万欧元Flanders Innovation and Entrepreneurship
-
2019-05-09A轮3000万欧元Wellington PartnersBioGeneration VenturesVIBV-BIO VenturesUniversity of MichiganPMVQbicCapricorn Health-Tech FundPerceptive AdvisorsFund +
相关投融资企业
B轮
Confo Therapeutics is a spin-off company of VIB and Vrije Universiteit Brussel focused on drugs targeting G-protein coupled receptors using its proprietary CONFO technology platform.In May 2019, Confo Therapeutics raised EUR 30 million (US $33.4 million) in Series A financing.In June 2015, the company raised EUR 3 million (US $3.37 million) in the first institutional round of investment by a consortium led by Capricorn Health-Tech Fund with the participation of Qbic and SOFI. In February 2016, the company had secured EUR 6.7 million (US $7.47 million) in the first financing round
捐赠/众筹/授予
Confo Therapeutics is a spin-off company of VIB and Vrije Universiteit Brussel focused on drugs targeting G-protein coupled receptors using its proprietary CONFO technology platform.In May 2019, Confo Therapeutics raised EUR 30 million (US $33.4 million) in Series A financing.In June 2015, the company raised EUR 3 million (US $3.37 million) in the first institutional round of investment by a consortium led by Capricorn Health-Tech Fund with the participation of Qbic and SOFI. In February 2016, the company had secured EUR 6.7 million (US $7.47 million) in the first financing round
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息